VirTra Reports Steep Financial Declines, Cites Material Weaknesses in Internal Controls
Summary
VirTra, Inc. reported a significant year-over-year decline in revenue, gross profit, net income, and Adjusted EBITDA for fiscal year 2025, alongside the disclosure of material weaknesses in its internal controls over financial reporting.
Key Events
-
Significant Financial Performance Decline
For fiscal year 2025, revenue decreased by 15% to $22.4 million, gross profit fell by 22% to $15.2 million, net income plummeted by 81% to $0.26 million, and Adjusted EBITDA dropped by 45% to $1.6 million, compared to 2024.
-
Material Weaknesses in Internal Controls
Management concluded that disclosure controls and internal control over financial reporting were not effective as of December 31, 2025, citing a lack of multiple management review levels on complex issues and inadequate system/manual controls.
-
Immaterial Financial Statement Error Correction
An immaterial error in the 2023 financial statements, related to a Canadian currency designation, resulted in a $498,000 overstatement of revenue, net income, and retained earnings, with a net reduction of $249,840 after other adjustments.
-
Orlando Office Purchase Agreement
The company executed a purchase agreement on March 6, 2026, to acquire its Orlando, Florida facility for $5 million, with closing expected in Q2 2026.
Analysis
VirTra, Inc.'s annual report reveals a challenging fiscal year 2025 marked by substantial declines across key financial metrics, including an 81% drop in net income and a 45% decrease in Adjusted EBITDA. These financial setbacks are attributed to external headwinds such as government shutdowns and federal funding delays. Compounding these concerns, the company disclosed material weaknesses in its internal controls over financial reporting and ineffective disclosure controls, which are critical issues for investor confidence and regulatory compliance. While the company maintains adequate liquidity and is working towards CMMC certification, the combination of poor financial performance and control deficiencies presents significant risks. Investors should monitor the company's efforts to remediate these control weaknesses and improve financial performance.
At the time of this filing, VTSI was trading at $4.02 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $50.1M. The 52-week trading range was $3.57 to $7.47. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.